Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach

Total article views   HTML views PDF downloads Totals
5,878 Dovepress* 5,413+ 1,101 6,514
PubMed Central* 465 158 623
Totals 5,878 1,259 7,137
*Since 16 April 2020

View citations on PubMed Central and Google Scholar